• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺炎链球菌中大环内酯类耐药基因型的分布及抗菌药物敏感性:PROTEKT研究第5年(2003 - 2004年)

Distribution and antibacterial susceptibility of macrolide resistance genotypes in Streptococcus pneumoniae: PROTEKT Year 5 (2003-2004).

作者信息

Farrell David J, Couturier Catherine, Hryniewicz Waleria

机构信息

G.R. Micro Ltd, 7-9 William Road, London NW1 3ER, UK.

出版信息

Int J Antimicrob Agents. 2008 Mar;31(3):245-9. doi: 10.1016/j.ijantimicag.2007.10.022.

DOI:10.1016/j.ijantimicag.2007.10.022
PMID:18178388
Abstract

The distribution and antibacterial susceptibility of macrolide resistance genotypes among 7083 Streptococcus pneumoniae isolates collected worldwide during 2003-2004 from patients with community-acquired respiratory tract infections, including patients within 48h of admission to hospital, were analysed. The overall rate of erythromycin resistance was 37.2% (intercountry range <10% to >50%). The most common resistance mechanism globally was erm(B) (55.0% of erythromycin-resistant S. pneumoniae (ERSP)), followed by mef(A) (30.6%) and erm(B)+mef(A) (12.0%). Genotype distribution varied by age group (P<0.0001); erm(B)+mef(A) was more prevalent (21.8% of isolates) among patients 0-2 years of age than among other age groups (P<0.001). The prevalence of tetracycline resistance among mef(A) isolates varied between different countries. Of the erm(B)+mef(A) strains, 43.5% were resistant to amoxicillin/clavulanic acid. Most ERSP isolates were susceptible to levofloxacin (98.3%) and telithromycin (99.4%).

摘要

对2003 - 2004年期间从社区获得性呼吸道感染患者(包括入院48小时内的患者)中收集的7083株肺炎链球菌分离株,分析了大环内酯类耐药基因型的分布及抗菌药敏情况。红霉素耐药的总体发生率为37.2%(国家间范围为<10%至>50%)。全球最常见的耐药机制是erm(B)(占红霉素耐药肺炎链球菌(ERSP)的55.0%),其次是mef(A)(30.6%)和erm(B)+mef(A)(12.0%)。基因型分布因年龄组而异(P<0.0001);erm(B)+mef(A)在0 - 2岁患者中比在其他年龄组中更普遍(占分离株的21.8%)(P<0.001)。不同国家间,mef(A)分离株中四环素耐药的发生率有所不同。在erm(B)+mef(A)菌株中,43.5%对阿莫西林/克拉维酸耐药。大多数ERSP分离株对左氧氟沙星(98.3%)和泰利霉素(99.4%)敏感。

相似文献

1
Distribution and antibacterial susceptibility of macrolide resistance genotypes in Streptococcus pneumoniae: PROTEKT Year 5 (2003-2004).肺炎链球菌中大环内酯类耐药基因型的分布及抗菌药物敏感性:PROTEKT研究第5年(2003 - 2004年)
Int J Antimicrob Agents. 2008 Mar;31(3):245-9. doi: 10.1016/j.ijantimicag.2007.10.022.
2
Distribution of capsular serotypes and macrolide resistance mechanisms among macrolide-resistant Streptococcus pneumoniae isolates in Korea.韩国大环内酯类耐药肺炎链球菌分离株的荚膜血清型分布及大环内酯类耐药机制
Diagn Microbiol Infect Dis. 2009 Feb;63(2):213-6. doi: 10.1016/j.diagmicrobio.2008.10.002. Epub 2008 Dec 18.
3
Distribution across the USA of macrolide resistance and macrolide resistance mechanisms among Streptococcus pneumoniae isolates collected from patients with respiratory tract infections: PROTEKT US 2001-2002.从呼吸道感染患者中分离出的肺炎链球菌菌株对大环内酯类药物的耐药性及耐药机制在美国的分布情况:2001 - 2002年美国肺炎链球菌耐药性监测研究(PROTEKT US)
J Antimicrob Chemother. 2004 Aug;54 Suppl 1:i17-22. doi: 10.1093/jac/dkh312.
4
Prevalence and antibacterial susceptibility of mef(A)-positive macrolide-resistant Streptococcus pneumoniae over 4 years (2000 to 2004) of the PROTEKT US Study.PROTEKT美国研究中4年(2000年至2004年)期间mef(A)阳性大环内酯类耐药肺炎链球菌的患病率及抗菌药敏情况
J Clin Microbiol. 2007 Feb;45(2):290-3. doi: 10.1128/JCM.01653-06. Epub 2006 Nov 8.
5
Antibacterial resistance patterns in Streptococcus pneumoniae isolated from elderly patients: PROTEKT years 1-5 (1999-2004).从老年患者中分离出的肺炎链球菌的抗菌耐药模式:PROTEKT研究的第1 - 5年(1999 - 2004年)
Int J Antimicrob Agents. 2007 Dec;30(6):546-50. doi: 10.1016/j.ijantimicag.2007.07.025. Epub 2007 Oct 10.
6
Mechanisms, molecular and sero-epidemiology of antimicrobial resistance in bacterial respiratory pathogens isolated from Japanese children.从日本儿童分离出的细菌性呼吸道病原体中抗菌药物耐药性的机制、分子及血清流行病学
Ann Clin Microbiol Antimicrob. 2007 Aug 13;6:7. doi: 10.1186/1476-0711-6-7.
7
Phenotypic and genotypic characterization of macrolide resistant Streptococcus pneumoniae recovered from adult patients with community-acquired pneumonia in an Argentinian teaching hospital.从阿根廷一家教学医院的社区获得性肺炎成年患者中分离出的大环内酯类耐药肺炎链球菌的表型和基因型特征
Int J Antimicrob Agents. 2005 Mar;25(3):260-3. doi: 10.1016/j.ijantimicag.2004.10.011. Epub 2005 Jan 21.
8
Prevalence and molecular analysis of macrolide and fluoroquinolone resistance among isolates of Streptococcus pneumoniae collected during the 2000-2001 PROTEKT US Study.2000 - 2001年美国PROTEKT研究期间收集的肺炎链球菌分离株中大环内酯类和氟喹诺酮类耐药性的流行情况及分子分析
J Clin Microbiol. 2004 Nov;42(11):4980-7. doi: 10.1128/JCM.42.11.4980-4987.2004.
9
Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).在加拿大呼吸道病原体药敏试验(CROSS,1998 - 2004年)的6年期间分离出的肺炎链球菌中的大环内酯类耐药机制。
J Antimicrob Chemother. 2007 Oct;60(4):733-40. doi: 10.1093/jac/dkm273. Epub 2007 Aug 2.
10
mef(A) is the predominant macrolide resistance determinant in Streptococcus pneumoniae and Streptococcus pyogenes in Germany.mef(A) 是德国肺炎链球菌和化脓性链球菌中主要的大环内酯类耐药决定因素。
Int J Antimicrob Agents. 2011 May;37(5):425-31. doi: 10.1016/j.ijantimicag.2011.01.019. Epub 2011 Mar 21.

引用本文的文献

1
Large-scale global molecular epidemiology of antibiotic resistance determinants in .关于……中抗生素耐药性决定因素的大规模全球分子流行病学研究 (原文句子不完整,翻译根据所给内容尽量完善)
Microb Genom. 2025 Jul;11(7). doi: 10.1099/mgen.0.001444.
2
The Crisis of Macrolide Resistance in Pneumococci in Latin America.拉丁美洲肺炎球菌对大环内酯类抗生素耐药性危机
Am J Trop Med Hyg. 2024 Jul 30;111(4):756-764. doi: 10.4269/ajtmh.23-0913. Print 2024 Oct 2.
3
Serotype, antibiotic susceptibility and whole-genome characterization of in all age groups living in Southwest China during 2018-2022.
2018年至2022年期间中国西南部所有年龄组的血清型、抗生素敏感性及全基因组特征
Front Microbiol. 2024 Feb 1;15:1342839. doi: 10.3389/fmicb.2024.1342839. eCollection 2024.
4
Serotype distribution, antimicrobial susceptibility and molecular epidemiology of invasive in the nine-year period in Serbia.塞尔维亚九年间侵袭性[病原体名称未完整给出]的血清型分布、抗菌药物敏感性及分子流行病学
Front Microbiol. 2023 Aug 21;14:1244366. doi: 10.3389/fmicb.2023.1244366. eCollection 2023.
5
An Overview of Macrolide Resistance in Streptococci: Prevalence, Mobile Elements and Dynamics.链球菌中大环内酯类耐药性概述:流行情况、移动元件及动态变化
Microorganisms. 2022 Nov 23;10(12):2316. doi: 10.3390/microorganisms10122316.
6
Characterization of Streptococcus pneumoniae Macrolide Resistance and Its Mechanism in Northeast China over a 20-Year Period.20 年来中国东北地区肺炎链球菌对大环内酯类药物耐药性的特征及其机制
Microbiol Spectr. 2022 Oct 26;10(5):e0054622. doi: 10.1128/spectrum.00546-22. Epub 2022 Aug 8.
7
Assessment of Long-Term Macrolide Exposure on the Oropharyngeal Microbiome and Macrolide Resistance in Healthy Adults and Consequences for Onward Transmission of Resistance.评估长期大环内酯类药物暴露对健康成年人口咽微生物组和大环内酯类耐药性的影响及其对耐药性传播的后果。
Antimicrob Agents Chemother. 2022 Apr 19;66(4):e0224621. doi: 10.1128/aac.02246-21. Epub 2022 Mar 16.
8
Characterization of Pneumococcal Colonization Dynamics and Antimicrobial Resistance Using Shotgun Metagenomic Sequencing in Intensively Sampled South African Infants.在密集采样的南非婴儿中使用鸟枪法宏基因组测序对肺炎球菌定植动态和抗菌药物耐药性进行表征
Front Public Health. 2020 Sep 22;8:543898. doi: 10.3389/fpubh.2020.543898. eCollection 2020.
9
Face mask sampling reveals antimicrobial resistance genes in exhaled aerosols from patients with chronic obstructive pulmonary disease and healthy volunteers.口罩采样揭示了慢性阻塞性肺疾病患者和健康志愿者呼出气溶胶中的抗菌药物耐药基因。
BMJ Open Respir Res. 2018 Sep 23;5(1):e000321. doi: 10.1136/bmjresp-2018-000321. eCollection 2018.
10
Synthesis of Both Enantiomers of Chiral Phenylalanine Derivatives Catalyzed by Cinchona Alkaloid Quaternary Ammonium Salts as Asymmetric Phase Transfer Catalysts.手性苯丙氨酸衍生物的对映异构体的全合成,由金鸡纳生物碱季铵盐作为不对称相转移催化剂催化。
Molecules. 2018 Jun 12;23(6):1421. doi: 10.3390/molecules23061421.